Tag: Kelun-Biotech Biopharmaceutical
Firms act on Kelun-Biotech’s HKD1.9bn H-share placement
Zhong Lun, S&C, Kirkland & Ellis advised on Kelun-Biotech’s HKEX H-share placement raising HKD1.94b (USD250m)
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
‘Family of marks’ doctrine in India
Family of marks doctrine under Indian law: Judicial origins, recognition criteria and infringement implications explained
White collars, dark intentions
Senior practitioners dissect how to tackle white-collar crime
Chasing zero
A closer look at how Japan and Taiwan are charting paths toward a low-carbon future
Q&A: INTA’s Walter Chia discusses IP from APAC viewpoint
Walter Chia, the chief representative officer for Asia-Pacific at INTA, elaborates on factors shaping IP across the region
